biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Question

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Aug 19, 2023 7:32pm

54 Views

Post# 35596611

RE:RE:Question

Well, TT, I imagine you don't have the courage to admit anything as embarrassing as a bankruptcy, or why you didn't become a pro hockey player. Fortunately, you're a bad poker player. You're so aware of your own shortcomings and your bad behaviour here that you can't even admit to your real name.

You say I have nothing. I have lots. I have intelligence, learning, and enduring skills. I have courage to put my own name behind what I say. And I have the opportunity to make it all work for me.

That makes the score five to nothing, TT.

I'm the five.

jd

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale